The saEPI and its individual components help identify children with asthma at high risk or low risk for a fall asthma exacerbation in the presence of guideline-based therapy with and without omalizumab.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2mddsEa
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου